ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

RGLS Regulus Therapeutics Inc

2.69
0.00 (0.00%)
시간외 단일가
최종 업데이트: 20:34:45
15분 지연
기업명 주식 심볼 시장 주식 타입
Regulus Therapeutics Inc RGLS 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 2.69 20:34:45
개장가 저가 고가 종가 전일 종가
2.69
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
30/04/202421:00PRNUSRegulus Therapeutics to Participate in the Canaccord Genuity..
22/03/202405:05PRNUSRegulus Therapeutics Reports Fourth Quarter and Year-End..
12/03/202419:32PRNUSRegulus Therapeutics Announces Oversubscribed $100 Million..
12/03/202419:30PRNUSRegulus Therapeutics Announces Positive Topline Data from..
19/01/202410:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/01/202410:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/01/202407:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/01/202407:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/01/202406:11EDGAR2Form S-8 - Securities to be offered to employees in employee..
10/01/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
03/01/202406:05PRNUSRegulus Therapeutics Announces Completion of Enrollment in..
28/12/202306:16EDGAR2Form S-3 - Registration statement under Securities Act of..
22/11/202322:00PRNUSRegulus Therapeutics to Present at the 6th Annual Evercore..
10/11/202306:39EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202306:15EDGAR2Form 8-K - Current report
10/11/202306:05PRNUSRegulus Therapeutics Reports Third Quarter 2023 Financial..
02/11/202321:00PRNUSRegulus Therapeutics Announces First Patient Dosed in Third..
19/10/202321:00PRNUSRegulus Therapeutics Advances to Cohort 3 of Phase 1b..
20/09/202320:00PRNUSRegulus Therapeutics Announces Positive Topline Data from..
13/09/202321:00PRNUSRegulus Therapeutics Announces Completion of Enrollment in..
05/09/202321:00PRNUSRegulus Therapeutics Announces Participation at Two..
23/08/202321:00PRNUSRegulus Therapeutics to Host Virtual Investor Event on..
15/08/202305:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/08/202305:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/08/202305:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/08/202305:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/08/202305:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/08/202305:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/08/202305:46EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/08/202305:15EDGAR2Form 8-K - Current report
09/08/202305:05PRNUSRegulus Therapeutics Reports Second Quarter 2023 Financial..
02/08/202321:00PRNUSRegulus Therapeutics to Present at the Canaccord Genuity..
18/07/202321:00PRNUSRegulus Therapeutics to Present at the H.C. Wainwright 2nd..
30/06/202305:53EDGAR2Form S-8 - Securities to be offered to employees in employee..
27/06/202321:00PRNUSRegulus Therapeutics Announces First Patient Dosed in Second..
23/06/202321:00PRNUSRegulus Therapeutics Announces Appointment of Preston S...
20/06/202321:00PRNUSRegulus Therapeutics Announces Update on Preclinical Studies..
12/06/202321:00PRNUSRegulus Therapeutics Strengthens Research & Development..
16/05/202321:00PRNUSRegulus Therapeutics Advances to Cohort 2 of Phase 1b..
12/05/202305:05PRNUSRegulus Therapeutics Reports First Quarter 2023 Financial..

최근 히스토리

Delayed Upgrade Clock